Tscan Therapeutics Inc (TCRX)

4.12 ↑0.00 (0.00%)
As of December 31, 1969, 7:00pm EST.

TCRX Chart

Your browser does not support this chart.

Your browser does not support this chart.

  • 52-Week Range: $4.12 - $9.51
  • Market Capitalization: $224.69M
  • Short Percentage: 5.66%
  • Target Price: $12.57
  • Shares Outstanding: 49.09M
  • Next Earnings: Nov 30
View More Stats

Catalysts

DateCategoryCatalyst
2022-03-24
Earnings

TCRX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $3.47 Close: -7.78% Next Day: -13.26% Next Week: -19.31% View More
0 Comments Share
Help your fellow traders

Company Info

Website: https://www.tscan.com
Address: 830 Winter Street, Waltham, MA, United States, 02451
Sector: Other
Industry: Other
Full time employees: 188

Stock Details

  • Current Price: $4.12
  • 52-Week Low: $4.12
  • 52-Week High: $9.51
  • Most Recent Quarter: 2024-06-30
  • Shares Float: 31.13M
  • Shares Outstanding: 49.09M
  • Market Capitalization: $224.69M
  • Next Earnings Date: 0000-00-00

Short Interest

  • Shares Short
    (Today):     0
  • Short Ratio: 0.00
  • Shares Short
    (Last Month):     0
  • Short Interest: 5.66%

The short interest for Tscan Therapeutics Inc is at 5.66%, which is low amongst its peers.

Stock Ownership

Your browser does not support this chart.

Retail: -0.12%
Insiders: 0.88%
Instutitions: 99.24%

Analyst Target Price

12.57

Tscan Therapeutics Inc is currently $8.45 below Wallstreet Analysts' price target.

Yesterday's Volume

165,472

Interest in Tscan Therapeutics Inc has been trending down. The average daily volume in the past 14 days is 311,416.

Discussions

Please log in or register to share your thoughts.

foreverbullish10/29/24 12:02am

$TCRX Waiting waiting waiting — you know for what !!! Announcement!!!

0 Like Report
rikishiiiii9/1/24 08:40am

$TCRX glad I didn’t chase this isn’t moving anytime soon with all of those call options here lol

0 Like Report
Modok9/1/24 03:20am

$TCRX super bullish

0 Like Report